AXQ Capital LP Lowers Position in Henry Schein, Inc. (NASDAQ:HSIC)

AXQ Capital LP trimmed its stake in Henry Schein, Inc. (NASDAQ:HSIC) by 33.6% in the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm owned 3,975 shares of the company’s stock after selling 2,015 shares during the quarter. AXQ Capital LP’s holdings in Henry Schein were worth $275,000 as of its most recent filing with the SEC.

A number of other institutional investors have also recently bought and sold shares of the stock. Versant Capital Management Inc lifted its position in Henry Schein by 274.6% during the fourth quarter. Versant Capital Management Inc now owns 457 shares of the company’s stock valued at $32,000 after buying an additional 335 shares in the last quarter. Venturi Wealth Management LLC lifted its position in Henry Schein by 3,347.1% during the fourth quarter. Venturi Wealth Management LLC now owns 586 shares of the company’s stock valued at $41,000 after buying an additional 569 shares in the last quarter. Quent Capital LLC lifted its position in Henry Schein by 91.2% during the fourth quarter. Quent Capital LLC now owns 677 shares of the company’s stock valued at $47,000 after buying an additional 323 shares in the last quarter. Smartleaf Asset Management LLC lifted its position in Henry Schein by 23.2% during the fourth quarter. Smartleaf Asset Management LLC now owns 759 shares of the company’s stock valued at $52,000 after buying an additional 143 shares in the last quarter. Finally, City State Bank acquired a new position in Henry Schein during the fourth quarter valued at approximately $55,000. 96.62% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Ratings Changes

A number of research firms have recently commented on HSIC. Barrington Research reissued an “outperform” rating and set a $90.00 target price on shares of Henry Schein in a research report on Wednesday, February 26th. UBS Group reduced their target price on shares of Henry Schein from $83.00 to $80.00 and set a “neutral” rating on the stock in a research report on Wednesday, February 26th. Wells Fargo & Company began coverage on shares of Henry Schein in a research report on Friday, February 14th. They set an “equal weight” rating and a $80.00 target price on the stock. Jefferies Financial Group boosted their target price on shares of Henry Schein from $77.00 to $80.00 and gave the stock a “hold” rating in a research report on Thursday, January 23rd. Finally, Bank of America raised shares of Henry Schein from an “underperform” rating to a “buy” rating and boosted their target price for the stock from $69.00 to $84.00 in a research report on Monday, January 6th. Six research analysts have rated the stock with a hold rating, five have assigned a buy rating and one has issued a strong buy rating to the company’s stock. According to MarketBeat, Henry Schein has a consensus rating of “Moderate Buy” and a consensus price target of $81.10.

Henry Schein Trading Down 1.5 %

HSIC opened at $69.39 on Monday. The stock has a market capitalization of $8.62 billion, a PE ratio of 28.56, a P/E/G ratio of 2.13 and a beta of 0.90. The firm’s fifty day moving average price is $74.82 and its 200 day moving average price is $72.64. The company has a debt-to-equity ratio of 0.46, a current ratio of 1.42 and a quick ratio of 0.82. Henry Schein, Inc. has a 12-month low of $63.67 and a 12-month high of $82.49.

Henry Schein (NASDAQ:HSIC) last released its earnings results on Tuesday, February 25th. The company reported $1.19 earnings per share for the quarter, missing the consensus estimate of $1.23 by ($0.04). Henry Schein had a net margin of 2.51% and a return on equity of 12.90%. The business had revenue of $3.19 billion for the quarter, compared to the consensus estimate of $3.25 billion. During the same quarter in the previous year, the firm earned $0.66 EPS. The firm’s revenue for the quarter was up 5.8% on a year-over-year basis. As a group, research analysts expect that Henry Schein, Inc. will post 4.74 EPS for the current fiscal year.

Insider Buying and Selling at Henry Schein

In other news, Director Philip A. Laskawy sold 2,604 shares of the company’s stock in a transaction dated Wednesday, March 19th. The shares were sold at an average price of $71.04, for a total transaction of $184,988.16. Following the completion of the transaction, the director now owns 24,805 shares in the company, valued at approximately $1,762,147.20. This represents a 9.50 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CEO Bradford C. Connett sold 4,036 shares of the company’s stock in a transaction dated Wednesday, March 19th. The stock was sold at an average price of $71.15, for a total transaction of $287,161.40. Following the transaction, the chief executive officer now owns 62,688 shares of the company’s stock, valued at $4,460,251.20. This represents a 6.05 % decrease in their position. The disclosure for this sale can be found here. 1.14% of the stock is owned by insiders.

Henry Schein Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.